| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | Pearson J. Michael | Chief Executive Officer | Nov 05, 2015 | Sale | $78.48 | 1,297,399 | 101,825,973 | 2,665,009 | Nov 09, 2015, 05:24 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Pearson J. Michael | Chief Executive Officer | Dec 14, 2013 | Buy | $81.41 | 184,247 | 14,999,549 | 4,025,498 | Dec 17, 2013, 04:10 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Pearson J. Michael | Chief Executive Officer | Aug 11, 2011 | Buy | $38.62 | 155,642 | 6,010,770 | 5,570,503 | Aug 15, 2011, 06:56 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Pearson J. Michael | Chief Executive Officer | Apr 21, 2011 | Option Exercise | $54.05 | 235,793 | 12,744,611 | 5,414,861 | Apr 26, 2011, 09:40 PM | |
| VRX | Valeant Pharmaceuticals International, Inc. | Pearson J. Michael | Chief Executive Officer | Feb 10, 2011 | Option Exercise | $39.50 | 929,364 | 36,709,878 | 5,650,654 | Feb 14, 2011, 09:54 PM |
Menu